HER2CLIMB-02: Tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer Meeting Abstract


Authors: Hurvitz, S. A.; Harbeck, N.; Vahdat, L.; Wolff, A. C.; Tolaney, S. M.; Loi, S.; Masuda, N.; O'Shaughnessy, J.; Xie, D.; Walker, L. N.; Rustia, E.; Borges, V.
Abstract Title: HER2CLIMB-02: Tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer
Meeting Title: ESMO Breast Cancer Virtual Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 2
Meeting Dates: 2021 May 5-8
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-05-01
Start Page: S75
Language: English
ACCESSION: WOS:000648924400130
DOI: 10.1016/j.annonc.2021.03.140
PROVIDER: wos
Notes: Meeting Abstract: 126TiP -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Linda T Vahdat
    43 Vahdat